Home » Arrayit to Bring First Pre-Symptomatic Ovarian Cancer Test to Market in 2010
Arrayit to Bring First Pre-Symptomatic Ovarian Cancer Test to Market in 2010
John Howell, CEO of Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation, Thursday formally commented on the anticipated timeline
for commercialization of its microarray-based OvaDx Pre-Symptomatic Ovarian Cancer Blood Test, which is currently advancing through late-stage development — the
rights to which have been assigned exclusively to the Company by Arrayit Corporation.
Yahoo!
Yahoo!
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May